Understanding on the pooled test for controlled clinical trials

Biometrical Journal

Volumn 43, Issue 7, 2001, Pages 909-923

  Lu, Hong Laura ^a   Huque, Mohammad ^b  

^a HFD 725   (United States)

^b NONE

Author keywords

Clinical trial; Interaction tests; Pooled tests; Power; Type I error rate

Indexed keywords

CONTROLLED DRUG DELIVERY; ERROR ANALYSIS;

ALTERNATIVE HYPOTHESIS; CLINICAL TRIAL; EFFECT SIZE; INTERACTION TEST; POOLED TEST; POWER; STATISTICAL EVIDENCE; TEST PROCEDURES; TREATMENT EFFECTS; TYPE I ERROR RATE;

MEDICAL APPLICATIONS;

EID: 0035643502     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4036(200111)43:7<909::aid-bimj909>3.0.co;2-o     Document Type: Article

References (8)

1. Food and Drug Administration. Statement Regarding the Demonstration of Effectiveness of Human Drug Products and Device. Federal Register, Vol 60, No. 147, August 1, 1995. Docket No. 95-0230, pp. 39180-39181.
2. Food and Drug Administration. Guidance for Industry: Providing Clinical Evidence of Effectiveness for Human Drug and Biological Products. May, 1998.
3. RUBERG, S. and CAIRNS, V., 1998: Providing Evidence of Efficacy for a New Drug. Statistics in Medicine, Vol 17, pp. 1813-1823.
4. FISHER, L. D., 1999: One Large, Well-Designed Multiple Center Study as An Alternative to the Usual FDA Paradigm. Drug Information Journal, Vol 33, pp. 265-271.
5. HUSTER, W. J. and LOUV, W. C., 1992: Demonstration of the Reproducibility of Treatment Efficacy from a Single Multicenter Trial. Journal of Biopharmaceutical Statistics, Vol. 2, pp. 219-238.
6. BICKEL, P. J. and DOKSUM, K. A., 1997: Mathematical Statistics. Holden Day, INC, pp. 198.
7. AZZALINI, A. and COX, D. R., 1984: Two New Tests Associated with Analysis of Variance. Journal of Royal Statistical Society, Vol 46, No 2, pp. 219-238.
8. GAIL, M. and SIMON, R.: Testing for Qualitative Interactions between Treatment Effects and Patient Subsets. Biometrics, Vol 41, pp. 361-372.